Navigation Links
Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
Date:6/17/2011

ructions, this side effect may be reduced or it may go away over time.

Extrapyramidal Symptoms (EPS) are usually persistent movement disorders or muscle disturbances, such as restlessness, tremors, and muscle stiffness. If you observe any of these symptoms, talk to your healthcare professional.

Some medications interact with RISPERDAL®. Please inform your healthcare professional of any medications or supplements that you are taking. Avoid alcohol while taking RISPERDAL®.

Inform your healthcare professional if you are pregnant or if you are planning to get pregnant while taking RISPERDAL®. Do not breast-feed if you are taking RISPERDAL®.

RISPERDAL® may affect your driving ability; therefore, do not drive or operate machinery before talking to your healthcare professional.

RISPERDAL® may affect alertness and motor skills; use caution until the effect of RISPERDAL is known.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995.  These statements are based on current expectations of future events.  If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Ortho-McNeil-Janssen Pharmaceuticals, Inc. and/or Johnson & Johnson.  Risks and uncertainties include, but are not limited to, general industry conditions and competition; economic factors, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and gove
'/>"/>

SOURCE Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Announces Oncology Research Collaboration Agreement with the Koch Institute for Integrative Cancer Research at MIT
2. The Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals to Develop Diabetes Therapy
3. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation of Past TOPAMAX(R) Marketing and Promotional Activities
4. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees to $75 Million Settlement for Topamax(R) False Claims Lawsuit
5. AUDIO from Medialink and Ortho-McNeil-Janssen Pharmaceuticals Inc.: Getting Ready for Cold and Flu Season
6. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
7. Omthera Pharmaceuticals, Inc. to Present at the 2011 Wells Fargo Securities Healthcare Conference
8. Pacira Pharmaceuticals, Inc. Announces FDA Extension of EXPAREL™ PDUFA Target Date by Three Months
9. Ampio Pharmaceuticals, Inc. Appoints New Independent Director
10. Aeolus Pharmaceuticals, Inc. Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
11. Pacira Pharmaceuticals, Inc. Appoints Two Life Sciences Industry Veterans to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3, 2015 Research and Markets ... "Investigation Report on China Olmesartan Market, 2010-2019" ... olmesartan medoxomil was successfully developed by Sankyo Pharmaceuticals Co., ... 2002, olmesartan medoxomil was approved by FDA to enter ... the best- selling drug in the world after it ...
(Date:9/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/84p6xc/investigation ) ... on China,s Bromhexine Market, 2010-2019" report to their ... of respiratory disease keeps growing and so does the ... of vasicine, is a mucolytic agent used in the ... or excessive mucus. It can make the phlegm thinner ...
(Date:9/3/2015)... WOONSOCKET, R.I. , Sept. 3, 2015  CVS ... Larry Merlo , the company,s president and chief ... president and chief financial officer, will be speaking to ... on September 17, 2015. They are scheduled to speak ... webcast of the presentation will be broadcast simultaneously through ...
Breaking Medicine Technology:China Olmesartan Investigation Market Report 2010-2019 2China Bromhexine Market Report 2015-2019 2
... Jan. 17, 2011 Perrigo Company (Nasdaq: PRGO;TASE) today announced ... fiscal 2011 on Tuesday, February 1, 2011 at approximately 8:00 ... 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo,s Chairman ... be available live via webcast to interested parties on the ...
... DJO Incorporated ("DJO" or the "Company"), a global provider ... pain management, today announced the planned retirement of Leslie H. ... Mr. Cross will transition into the vital and important role ... now and June 30, 2011. "It is my good fortune ...
Cached Medicine Technology:DJO Incorporated Announces Planned Transition of President and CEO Les Cross 2DJO Incorporated Announces Planned Transition of President and CEO Les Cross 3
(Date:9/3/2015)... ... 03, 2015 , ... IQ Formulations today was ... economic development group GrowFL and the Edward Lowe Foundation. The leading health supplement ... prestigious award, which recognizes growing second-stage companies “that demonstrate high performance in the ...
(Date:9/3/2015)... ... 03, 2015 , ... For many patients with lymphedema, health ... garments are an effective solution for reducing the medical costs associated with their ... by SIGVARIS for a unique opportunity to meet with Jim Cooper, ...
(Date:9/3/2015)... ... September 03, 2015 , ... Today, Splashtop ... Suite customers, as part of the LANDESK One Partner program. Splashtop ... the best mobile user experience in remote access and control:, ...
(Date:9/3/2015)... ... September 03, 2015 , ... RealtyShares , ... accredited and institutional investors to real estate investment opportunities nationwide, today announced that ... from both investors and sponsoring real estate companies. , These products ...
(Date:9/3/2015)... ... September 03, 2015 , ... Advice ... release of her debut book, “Stop Wasting Your Time Blaming Others for Your ... 6), Hartley’s guide to overcoming life’s obstacles by taking full responsibility for one’s ...
Breaking Medicine News(10 mins):Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 2Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 3Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 4Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 3
... 28 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky ... ), a,leading fully integrated pharmaceutical company producing over-the-counter,drugs in ... the,Company is scheduled to launch a non-deal roadshow ("NDR") ... China Sky One Medical,s Chief ...
... Adjusted EBITDA , , VANCOUVER, July 28 /PRNewswire-FirstCall/ - ... or the "Company") today reported financial results for the second ... are in U.S. dollars and in accordance with U.S. GAAP. ... with robust Eligard(R) sales of $67.6 million, sequential Visudyne(R) sales ...
... , , ... systems biology company, today announced that it has been awarded ... pharmacogenomic research. The SBIR grant, funded through the innovations in ... develop a database and systems biology tool-set specifically designed for ...
... , GLEN ROCK, N.J., July 28 ... version of Fingertip Formulary Accounts((R)), a state-of-the art web-based ... care data and resources at an account level. ... and now provides immediate, real-time integrated provider-level data that ...
... , , , LONDON, ... have started to integrate many IT-based ancillary systems such as ... a service-oriented business, in which IT systems have accelerated healthcare ... physicians and radiologists is creating a challenge for hospitals. A ...
... Pediatricians can now ... to trusted health information online. , ... Berkeley, Calif. (PRWEB) July 28, 2009 -- Vivacare has expanded its free ... education tools that improve clinical care and save time and money, , , ,The child ...
Cached Medicine News:Health News:China Sky One Medical, Inc. to Conduct Non-Deal Roadshow in Hong Kong and Singapore 2Health News:QLT Announces Second Quarter Results for 2009 2Health News:QLT Announces Second Quarter Results for 2009 3Health News:QLT Announces Second Quarter Results for 2009 4Health News:QLT Announces Second Quarter Results for 2009 5Health News:QLT Announces Second Quarter Results for 2009 6Health News:QLT Announces Second Quarter Results for 2009 7Health News:QLT Announces Second Quarter Results for 2009 8Health News:QLT Announces Second Quarter Results for 2009 9Health News:QLT Announces Second Quarter Results for 2009 10Health News:QLT Announces Second Quarter Results for 2009 11Health News:QLT Announces Second Quarter Results for 2009 12Health News:QLT Announces Second Quarter Results for 2009 13Health News:QLT Announces Second Quarter Results for 2009 14Health News:QLT Announces Second Quarter Results for 2009 15Health News:QLT Announces Second Quarter Results for 2009 16Health News:QLT Announces Second Quarter Results for 2009 17Health News:GeneGo Awarded NIH Grant to Develop Pharmacogenomics Software Suite 2Health News:Fingertip Formulary Accounts(R) Now Offers Access to Comprehensive Real-Time Account Information and Integrated Formulary Data, in a State-of-the Art Web-Based Platform 2Health News:Radiology Informatics: Frost & Sullivan Examines the Next Big Wave in Medicine 2Health News:Vivacare Expands Patient Education Service to Pediatricians 2Health News:Vivacare Expands Patient Education Service to Pediatricians 3
... OptiMumm™ smoke evacuator is ... complete smoke evacuation system ... AccuVac™ smoke evacuation attachment, ... and either the Force ...
... Knee Positioner reduces surgeon fatigue and assists in ... The positioner's single locking lever allows for ... The same lever releases the boot for testing ... The positioner is easily set up on ...
... The adjustable height permits optimal leg position ... application of a cast with the foot/ankle at ... placed on the tongue of the stand. Stockinette ... padding and plaster/fiberglass is used in a routine ...
CEMEX Fast Set is a solution for multiple indications and preferences. It is a self-contained delivery system in a convenient 70gm size....
Medicine Products: